| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC2847 |
| Trial ID | NCT05127135 |
| Disease | T-Cell Acute Lymphoblastic Leukemia | T-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ThisCAR-T7 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | Fundamenta Therapeutics, Ltd. |
| Other ID(s) | ThisCART7 |
| Cohort 1 | |||||||||||
|
|||||||||||